Real-World Utilization of Carfilzomib (Once or Twice Weekly) Initiated in Patients After a First Relapse Between 2017 and 2022 in France: An Analysis From a Large-Scale Epidemiology of Multiple MYeloma (EmmY) Cohort.

Saved in:
Bibliographic Details
Title: Real-World Utilization of Carfilzomib (Once or Twice Weekly) Initiated in Patients After a First Relapse Between 2017 and 2022 in France: An Analysis From a Large-Scale Epidemiology of Multiple MYeloma (EmmY) Cohort.
Authors: Hulin C; Department of Clinical Hematology and Cellular Therapy, University Hospital Bordeaux, Pessac, France. Electronic address: cyrille.hulin@chu-bordeaux.fr., Belhadj Merzoug K; Department of Lymphoid Hematology, Henri Mondor Hospital, Créteil, France., Royer B; Department of Immuno-Hematology, Saint-Louis Hospital, Paris, France., Caillot D; Department of Clinical Hematology, University Hospital Dijon, Dijon, France., Bobin A; Department of Hematology, University Hospital Poitiers, Poitiers, France., Macro M; Department of Hematology, University Hospital Caen, Caen, France., Karlin L; Department of Hematology, University Hospital South Lyon, Pierre-Bénite, France., Mohty M; Department of Clinical Hematology and Cellular Therapy, Sorbonne University, Saint-Antoine Hospital (AP-HP), Paris, France., Frenzel L; Department of Adult Hematology, Necker Hospital for Sick Children, Paris, France., Perrot A; Department of Hematology, Cancer University Institute of Toulouse (IUCT) Oncopole, Toulouse, France., Vincent L; Department of Clinical Hematology, University Hospital Montpellier, Montpellier, France., Dib M; Department of Hematology, Regional University Hospital Angers (Bocage Hospital), Angers, France., Piocell FO; Department of Hematology, Annecy Genevois Hospital, Pringy, France., Benramdane R; Department of Clinical Hematology, René Dubos Hospital, Cergy Pontoise, France., Calmettes C; Department of Onco-Hematology, Périgueux Hospital, Périgueux, France., Chalopin T; Department of Hematology and Cellular Therapy, Regional University Hospital Tours, Tours, France., Garlantézec R; Department of Public Health and Epidemiology, University Hospital Rennes, Rennes, France., Désaméricq G; Department of Health-economics, Amgen SAS, Courbevoie, France., Mechiche H; Medical Department, Amgen SAS, Courbevoie, France., Decaux O; Department of Clinical Hematology, University Hospital Rennes, Rennes, France.
Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2026 Jan; Vol. 26 (1), pp. e1-e11.e4. Date of Electronic Publication: 2025 Aug 07.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2152-2669
DOI:10.1016/j.clml.2025.08.002